Vermersch P, Oreja-Guevara C, Siva A, Van Wijmeersch B, et al. Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial. Eur J Neurol 2022;29:790-801.
PMID: 34748672